focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: 13.00 (2.75%)
Spread: 10.00 (2.083%)
Open: 472.50
High: 485.00
Low: 472.50
Prev. Close: 472.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

3 Aug 2021 07:00

RNS Number : 3210H
Warpaint London PLC
03 August 2021
 

3 August 2021

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Appointment of Non-Executive Director

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, is pleased to announce the appointment of Mr John Collier as an independent Non-executive Director of the Company with effect from 1 September 2021.

Mr Collier is a Canadian national, based in New York, USA, who has spent nearly 30 years in the consumer goods industry, primarily at Revlon, the multinational cosmetics, skin care, fragrance, and personal care company. More recently, Mr Collier has been appointed as President of Swiss oral beauty and health company, vVARDIS Inc. Prior to founding his own New York based advisory business he was at Revlon between 1996 and 2018, latterly as President, North America. In this role he managed operations with approximately US$1.7 billion of annual sales, with responsibility for brand assets and commercial relationships spanning direct, e-commerce, speciality and prestige sales channels. His prior roles at Revlon included senior management positions with responsibility for brand and market development, including implementing e-commerce strategies.

 

Mr Collier will be a member of the Company's remuneration committee and its audit committee.

 

Commenting, Clive Garston, Chairman of Warpaint, said:

"We are very pleased to welcome John to the Warpaint board. He brings with him a wealth of experience in the cosmetics sector, including implementing sales strategies and brand development, covering both traditional and online sales channels. John brings extensive and valuable experience that will be particularly beneficial as we seek to grow our North American business."

 

Regulatory disclosures

 

The following disclosures are made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

John Travis Collier, aged 50, has, or has been during the last five years, a director or partner of the following companies/partnerships:

 

Current directorships/partnerships

Vvardis

Coldon Group

Ross Institute

 

Previous directorships/partnerships

Revlon

 

Mr Collier holds no ordinary shares in the Company.

 

There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) or Rule 17 of the AIM Rules for Companies.

 

Enquiries:

Warpaint London

c/o IFC

Clive Garston - Chairman

Sam Bazini - Chief Executive Officer

Keith Sadler - Non-executive Director

 

 

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

020 7496 3000

Shaun Dobson, Tom Salvesen, Jen Boorer, Alex Bond - Investment Banking

 

Shore Capital (Joint Broker)

020 7408 4090

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

 

Warpaint London plc

 

Warpaint is made up of two divisions.

 

The largest division sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using our other own brand names of Man'stuff, Body Collection, Vintage, Very Vegan, and Chit Chat.

 

The other division trades in close-out and excess inventory of branded cosmetics and fragrances from around the world.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDIIXGDGBD
Date   Source Headline
15th Jun 20207:00 amRNSEquity Development Investor Webinar
1st Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20202:00 pmRNSNotice of AGM and Posting of Annual Report
1st Jun 20207:00 amRNSFurther UK Retail Expansion
21st May 20207:00 amRNSShare Option Plan, Grant of Options & PDMR Holding
13th May 20207:00 amRNSFinal Results for the year ended 31 December 2019
11th May 20204:29 pmRNSHolding(s) in Company
29th Apr 20204:35 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSCovid-19 Update and Notice of Results
19th Mar 20207:00 amRNSUpdate regarding Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSUK Retail Expansion & Trading Update
20th Dec 20197:00 amRNSTrading Update
16th Oct 20194:28 pmRNSDirector Dealings
24th Sep 20197:08 amRNSHolding(s) in Company
20th Sep 20192:25 pmRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
19th Aug 20197:00 amRNSAppointment of Joint Broker
6th Aug 20197:00 amRNSTrading Update and Notice of Results
11th Jun 20197:00 amRNSChange of Adviser
21st May 20191:54 pmRNSHolding(s) in Company
21st May 201911:55 amRNSResult of AGM
21st May 201910:59 amRNSAGM Statement
26th Apr 20192:10 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:13 pmEQSHardman & Co Research: Warpaint London Plc (W7L): FY'18 sales: remains profitable despite weak UK market
10th Apr 20197:00 amRNSResults for the 12 months ended 31 December 2018
3rd Apr 20197:00 amRNSNotice of Results
11th Mar 20193:19 pmRNSHolding(s) in Company
22nd Feb 20194:21 pmRNSHolding(s) in Company
20th Feb 201912:58 pmRNSHolding(s) in Company
29th Jan 20197:00 amRNSTrading Update
1st Nov 201812:45 pmEQSHardman & Co Research: Warpaint London Plc (W7L): Trading update: softening UK market
31st Oct 20187:00 amRNSHolding(s) in Company
30th Oct 201811:52 amRNSDirector Dealings
29th Oct 20189:05 amRNSSecond Price Monitoring Extn
29th Oct 20189:00 amRNSPrice Monitoring Extension
29th Oct 20187:00 amRNSTrading Update
4th Oct 20185:30 pmEQSHardman & Co Research: Warpaint London Plc (W7L): 1H'18 interims: delivering the results
4th Oct 20185:10 pmEQSHardman & Co Research: Diurnal Group (DNL): First commercial revenues
24th Sep 20187:00 amRNSImplementation of Long-term Incentive Plan
21st Sep 20184:37 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSAppointment of Director
17th Sep 20187:00 amRNSInterim Results for the 6 months to 30 June 2018
3rd Sep 20187:00 amRNSNotice of Results
3rd Aug 20187:00 amRNSAcquisition of USA Distributor
19th Jun 20187:00 amRNSDirector Dealings
13th Jun 20182:43 pmEQSHardman & Co Research: Warpaint London PLC (W7L): Painting a bright future

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.